RABINOWITZ DANIEL

CFO/Chief Legal Officer Daniel Rabinowitz sells 8,400 shares of NTRA for $1.7M at $203.31 blended price

Daniel Rabinowitz, SEC and Chief Legal Officer, executed 5 separate sales totaling 8,400 shares for $1,707,814.32 on 2026-04-01, reducing his holdings by 3.6% to 224,885 shares. The blended average price of $203.31 compares to the current price of $207.98, placing the sale 1.8% below current market levels. Rabinowitz's cross-ticker track record shows 20 prior sells with an average 90-day return of -1.6% and a 90-day well-timed rate of 53.85%, though his prior trades at NTRA (five sales on 2026-03-06) remain too recent to measure outcome. The company remains unprofitable with net income of $-87,544,000.00 in the latest quarter, despite annual revenue growth of +35.9%, context that provides backdrop for executive equity reduction rather than a clear signal of adverse expectations at this price level.

Chief Legal Officer Daniel Rabinowitz sold 8,398 shares ($1.6M) across 5 transactions on 2026-03-06, reducing holdings by 3.5%.

Daniel Rabinowitz, SEC and Chief Legal Officer at Natera, executed five separate sales totaling 8,398 shares for $1,646,695.83 at prices ranging from $193.73 to $198.04 on 2026-03-06, bringing post-transaction holdings to 233,285 shares. At his same-ticker NTRA history, 0 of 3 prior measurable sales proved well-timed at the 90-day mark—all three resulted in positive 90-day returns, indicating the stock rose after each sale. The current price of $198.95 sits -21.8% from the 52-week high of $254.40, and the stock has declined -14.7% over 90 days, yet this represents a modest 3.5% reduction in a substantial 233.3K-share position. NTRA's underlying business generated $592.2M in quarterly revenue with +35.9% annual growth, though the company reported -$87.5M in net income and remains unprofitable on a full-year basis.

Natera CFO Daniel Rabinowitz sold 19,672 shares (19.7K shares) for $4,617,888.39 ($4.6M) on 2026-01-20/21

Rabinowitz, Secretary and Chief Legal Officer, executed 2 separate sales totaling 19,672 shares for $4,617,888.39, reducing his stake from 246,705 shares to 227,033 shares (-8.0%). The sales occurred at a blended average price of $234.74, modestly below the current price of $242.91. His prior 5 sales at NTRA show mixed results: 1 of 5 were well-timed at the 90-day mark, with the most recent sale (2025-07-21) performing best (+30.4% over 90 days). Cross-ticker, his 19 prior sells averaged a 90d well-timed rate of 36.84%, slightly above 50% chance. Against this backdrop, Rabinowitz maintains substantial holdings of 227.0K shares post-transaction in a company with $592.2M quarterly revenue growing +56.8% annually, though the company remains unprofitable (net income -$87.5M on latest quarter). The sale is material in dollar terms but represents a modest portfolio reduction.

NTRA Chief Legal Officer Daniel Rabinowitz sells 20.4K shares across 4 transactions for $3.5M; stock down 21.0% from 52-week high post-transaction.

Daniel Rabinowitz, SEC and Chief Legal Officer, executed 4 separate sales totaling 20,372 shares for $3,459,007.13 over a one-month window (June 18 to July 21), reducing his position from 224,530 to 204,158 shares. The blended average sale price of $169.79 now sits well above the current price of $139.92—a 21.0% gap—and the stock has declined 18.6% in the 30 days since his first sale. His prior 5 same-ticker sales at NTRA each exhibited negative 90-day returns, with a 100% well-timed rate, and his cross-ticker track record shows 46.67% well-timed sells. The company remains unprofitable (net income $-66,936,000.00 on revenue $501,830,000.00 for the latest quarter), though revenue growth is strong at +56.8% annually. The combination of a senior legal officer's multi-tranche exit during a declining stock, the material gap between sale prices and current levels, and a demonstrated pattern of well-timed selling at this ticker merits close investor review of recent developments affecting the company's outlook.

NTRA Chief Legal Officer sold 4,773 shares for $791,693.97 (blended avg $165.87); stock at $176.92, +11.8% in 30 days, +42.5% in 90 days.

Daniel Rabinowitz, Secretary and Chief Legal Officer, completed 3 separate sales totaling 4,773 shares for $791,693.97 on 2025-01-29, reducing holdings by 2.2% to 213,020 shares post-transaction. The sales occurred at an average price of $165.87, while the current market price of $176.92 reflects a substantial rally—the stock has appreciated +11.8% over the prior 30 days and +42.5% over the prior 90 days, now trading at the 52-week high. At NTRA specifically, his most recent prior measurable sales (May 2024) yielded positive 90-day returns of +8.0% and +9.5%, while the company remains unprofitable with net income of $-31,592,000 on revenue of $439,758,000 despite strong 32% annual revenue growth. The timing of this sale in a steeply appreciating stock environment, coupled with recent sell activity in January at NTRA and a broader cross-ticker sell history (90-day well-timed rate of 11.11%), warrants observation to track whether the stock's momentum continues or begins to consolidate post-sale.

Chief Legal Officer Daniel Rabinowitz sold 22,039 shares of Natera at avg $164.97 for $3.6M on 2025-01-22

Rabinowitz executed 2 separate sales totaling 22,039 shares for $3,635,684.56, reducing his holdings by 9.2% from 239,832 to 217,793 shares. The sales occurred near the 52-week high (current price $171.93 is -2.6% from the $176.61 peak), following a strong 90-day rally of +44.3%. At NTRA specifically, his prior 4 measurable sales (all in May 2024) showed mixed timing: only 1 of 4 was well-timed at the 90-day mark, with returns ranging from +9.5% to +2.9% over 30 days and +6.1% to -0.4% over 90 days. The company is unprofitable (net income $-31.6M) despite 32.0% annual revenue growth, which adds uncertainty to the stock's near-peak valuation at $22.7B market cap.

NTRA: Chief Legal Officer Rabinowitz sells 6,223 shares at $175.30; stock near 52-week high, unprofitable company

Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, sold 6,223 shares for $1,090,901.23 on 2025-01-08 at $175.30, reducing his holdings to 199,804 shares. The sale occurred when the stock was -0.9% from its 52-week high of $176.61, following strong recent momentum of +4.7% over 30 days and +34.6% over 90 days. Natera remains unprofitable with net income of $-31,592,000.00 against quarterly revenue of $439,758,000.00, despite 32.0% annual revenue growth. Across his cross-ticker track record, Rabinowitz's prior 9 sells averaged +7.6% return over 30 days and +18.1% over 90 days, with a 11.11% well-timed rate; his prior 5 trades at NTRA specifically showed only 1 well-timed outcome at the 90-day mark, suggesting limited predictive power in this security.